Vertex Pharmaceuticals
VRTX
VRTX
930 hedge funds and large institutions have $41.8B invested in Vertex Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 97 funds opening new positions, 356 increasing their positions, 347 reducing their positions, and 130 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $46.7B → $41.8B (-$4.9B)
25% less first-time investments, than exits
New positions opened: 97 | Existing positions closed: 130
60% less funds holding in top 10
Funds holding in top 10: 15 → 6 (-9)
Holders
930
Holding in Top 10
6
Calls
$501M
Puts
$527M
Top Buyers
| 1 | +$967M | |
| 2 | +$525M | |
| 3 | +$292M | |
| 4 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
+$281M |
| 5 |
Two Sigma Investments
New York
|
+$187M |
Top Sellers
| 1 | -$1.44B | |
| 2 | -$430M | |
| 3 | -$420M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$281M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$187M |